Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Gensight Biologics SA buy Lokrim

Start price
€2.45
21.12.19 / 50%
Target price
-
12.01.20
Performance (%)
65.92%
End price
€4.07
12.01.20
Summary
This prediction ended on 12.01.20 with a price of €4.07. With a performance of 65.92% the BUY prediction by Lokrim was a big success. Lokrim has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Gensight Biologics SA 1.552% 1.552% -39.893% -94.767%
iShares Core DAX® 1.804% -0.748% 13.168% 16.408%
iShares Nasdaq 100 -0.182% -3.412% 39.976% 43.502%
iShares Nikkei 225® 0.413% -7.381% 18.776% 2.874%
iShares S&P 500 0.664% -1.941% 28.141% 42.155%

According to Lokrim what are the pros and cons of Gensight Biologics SA for the foreseeable future?

Pros
Cons
Risky Investment

Comments by Lokrim for this prediction

In the thread Gensight Biologics SA diskutieren

Buy Gensight Biologics SA

Prediction Buy
Perf. (%) 65.92%
Target price
Change
Ends at 12.01.20

Buy beendet

Stopped prediction by Lokrim for Gensight Biologics SA

Gensight Biologics SA

Start price
Target price
Perf. (%)
€2.97
07.03.22
-
07.03.23
-19.53%
08.03.23

Risky Investment
buy
Gensight Biologics SA

Start price
Target price
Perf. (%)
€4.07
12.01.20
-
04.11.21
35.92%
05.11.21

Risky Investment